Evaluation of Feature Selection for Alzheimer's Disease Diagnosis

Front Aging Neurosci. 2022 Jun 24:14:924113. doi: 10.3389/fnagi.2022.924113. eCollection 2022.

Abstract

Accurate recognition of patients with Alzheimer's disease (AD) or mild cognitive impairment (MCI) is important for the subsequent treatment and rehabilitation. Recently, with the fast development of artificial intelligence (AI), AI-assisted diagnosis has been widely used. Feature selection as a key component is very important in AI-assisted diagnosis. So far, many feature selection methods have been developed. However, few studies consider the stability of a feature selection method. Therefore, in this study, we introduce a frequency-based criterion to evaluate the stability of feature selection and design a pipeline to select feature selection methods considering both stability and discriminability. There are two main contributions of this study: (1) It designs a bootstrap sampling-based workflow to simulate real-world scenario of feature selection. (2) It develops a decision graph to determine the optimal combination of supervised and unsupervised feature selection both considering feature stability and discriminability. Experimental results on the ADNI dataset have demonstrated the feasibility of our method.

Keywords: Alzheimer’s disease; artificial intelligence; discriminability; feature selection; stability.